Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH-HCC Guidelines)
- PMID: 36826411
- DOI: 10.1111/hepr.13892
Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH-HCC Guidelines)
Abstract
The fifth version of the Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of evidence-based medicine and partly to the Grading of Recommendations Assessment, Development and Evaluation system, which was published in October 2021 in Japanese. In addition to surveillance-diagnostic and treatment algorithms, a new algorithm for systemic therapy has been created, as multiple drugs for hepatocellular carcinoma can be currently selected. Here, new or revised algorithms and evidence on which the recommendations are based are described.
Keywords: algorithm for surveillance and diagnosis; algorithm for systemic therapy; algorithm for treatment; clinical practice guidelines; hepatocellular carcinoma.
© 2023 The Authors. Hepatology Research published by John Wiley & Sons Australia, Ltd on behalf of Japan Society of Hepatology.
Similar articles
-
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update.Hepatol Res. 2019 Oct;49(10):1109-1113. doi: 10.1111/hepr.13411. Epub 2019 Sep 6. Hepatol Res. 2019. PMID: 31336394
-
Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines).Hepatol Res. 2015 Jan;45(2). doi: 10.1111/hepr.12464. Hepatol Res. 2015. PMID: 25625806
-
Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update.Liver Cancer. 2021 Jun;10(3):181-223. doi: 10.1159/000514174. Epub 2021 May 19. Liver Cancer. 2021. PMID: 34239808 Free PMC article. Review.
-
Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.Dig Dis. 2011;29(3):339-64. doi: 10.1159/000327577. Epub 2011 Aug 9. Dig Dis. 2011. PMID: 21829027
-
Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology.Oncology. 2007;72 Suppl 1:2-15. doi: 10.1159/000111702. Epub 2007 Dec 13. Oncology. 2007. PMID: 18087177 Review.
Cited by
-
Clinical Outcomes of Next-Generation Microwave Thermosphere Ablation for Hepatocellular Carcinoma with Primarily Hepatitis-Related Etiology.J Clin Med. 2023 Dec 8;12(24):7577. doi: 10.3390/jcm12247577. J Clin Med. 2023. PMID: 38137645 Free PMC article.
-
Diagnostic performance of magnetic resonance imaging and contrast-enhanced ultrasound in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma: a meta-analysis.Abdom Radiol (NY). 2024 Jan;49(1):34-48. doi: 10.1007/s00261-023-04064-z. Epub 2023 Oct 12. Abdom Radiol (NY). 2024. PMID: 37823913
-
Clinicopathological features of hepatoid adenocarcinoma of the stomach: A multicenter retrospective study.Cancer Rep (Hoboken). 2024 Jun;7(6):e2101. doi: 10.1002/cnr2.2101. Cancer Rep (Hoboken). 2024. PMID: 38831124 Free PMC article.
-
Clinical Utility of the Novel Oncological Criteria of Resectability for Advanced Hepatocellular Carcinoma.Liver Cancer. 2024 May 16;13(6):601-609. doi: 10.1159/000539381. eCollection 2024 Dec. Liver Cancer. 2024. PMID: 39687034 Free PMC article.
-
Transarterial Chemoembolization for Hepatocellular Carcinoma: Current Role and Techniques.Interv Radiol (Higashimatsuyama). 2024 Oct 4;10:e20240016. doi: 10.22575/interventionalradiology.2024-0016. eCollection 2025 Mar 28. Interv Radiol (Higashimatsuyama). 2024. PMID: 40384908 Free PMC article. Review.
References
REFERENCES
-
- Makuuchi M, Kokudo N. Clinical practice guidelines for hepatocellular carcinoma: the first evidence-based guidelines Japan. World J Gastroenterol. 2006;12:828-9.
-
- Makuuchi M, Kokudo N, Arii S, Futagawa S, Kaneko S, Kawasaki S, et al. Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res. 2008;38(1):37-51. https://doi.org/10.1111/j.1872-034x.2007.00216.x
-
- Makuuchi M, Kokudo N. Clinical practice guidelines for hepatocellular carcinoma - The Japan Society of Hepatology 2009 update. Hepatol Res. 2010;40(Suppl 1):2-144.
-
- Kokudo N, Hasegawa K, Akahane M, Igaki H, Izumi N, Ichida T, et al. Evidence-based clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC guidelines). Hepatol Res. 2015;45(2):123-7. https://doi.org/10.1111/hepr.12464
-
- Kokudo N, Takemura N, Hasegawa K, Takayama T, Kubo S, Shimada M, et al. Clinical practice guidelines for hepatocellular carcinoma: the Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update. Hepatol Res. 2019;49(10):1109-13. https://doi.org/10.1111/hepr.13411
Grants and funding
LinkOut - more resources
Full Text Sources